Skip to main navigation

About
R&D
Pipeline
Investors & Media
Careers

Investors & Media

Overview
News
Events & Presentations
Annual Reports
Stock Information
- Stock Quote & Chart
- Analyst Coverage
SEC Filings
Corporate Governance
Investor Resources
- FAQs
- Investor Contact

News

Year

August 12, 2020

NGM Bio Provides Business Highlights and Reports Second Quarter 2020 Financial Results

July 31, 2020

NGM Bio to Present at Two Upcoming Investor Conferences

July 27, 2020

NGM Bio Announces Initiation of Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

June 8, 2020

NGM Bio Expands Board of Directors with Appointment of Carole Ho, M.D.

Pagination

Current page 1
Page 2
Page 3
Page 4
Next page
Last page

Displaying 1 - 4 of 14

Stock Quote

Contact Information

Investor Relations:
ir@ngmbio.com

Media Relations:
media@ngmbio.com

Toolkit

© 2020 NGM Biopharmaceuticals.

All Rights Reserved.

Privacy Policy.

Top